[Current therapeutics 2000]

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

[Major depressive episode with psychotic features and vitamin B12 deficiency : a neuropsychiatric interplay].

Revue medicale de Liege·2026

[Comparison of multidisciplinary spine rehabilitation programs for patients with chronic low back pain in French-speaking Belgium].

Revue medicale de Liege·2026

[Acute anterior ischemic optic neuropathy in the context of mitochondrial disease].

Revue medicale de Liege·2026

[Anaphylaxis to MMR vaccine gelatin : practical recommendations].

Revue medicale de Liege·2026

[Evaluation of the use of virtual reality hypnosis during Port-a-cath® placement in adult oncology patients as an effective alternative to intravenous sedation : a pilot study].

Revue medicale de Liege·2026

[Type 1 diabetes, towards new horizons].

Revue medicale de Liege·2026

Structure-activity profiling of indazole-based derivatives as spinster homolog 2 (Spns2)-dependent S1P release inhibitors.

Bioorganic & medicinal chemistry letters·2026

Triterpenoids and lignans from the stems of Tripterygium wilfordii and their hepatoprotective activities.

Fitoterapia·2026

An integrated in vitro and in silico approach to evaluate the safety and wound healing potential of Dracocephalum moldavica L. seed oil.

Toxicology in vitro : an international journal published in association with BIBRA·2026

Unraveling the allosteric inhibition mechanism of TLR2 by CU-CPT22: A combined DFT and enhanced sampling MD study.

Journal of molecular graphics & modelling·2026

Discovery of pyrimidine-based dual CDK2/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights.

Bioorganic chemistry·2026

Oleanolic acid-selenocyanate hybrids trigger replication-associated DNA damage responses and suppress tumour growth in vitro and in vivo.

Bioorganic chemistry·2026

Related Experiment Videos

[Current therapeutics 2000]

Related Concept Videos

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

[Major depressive episode with psychotic features and vitamin B12 deficiency : a neuropsychiatric interplay].

[Comparison of multidisciplinary spine rehabilitation programs for patients with chronic low back pain in French-speaking Belgium].

[Acute anterior ischemic optic neuropathy in the context of mitochondrial disease].

[Anaphylaxis to MMR vaccine gelatin : practical recommendations].

[Evaluation of the use of virtual reality hypnosis during Port-a-cath® placement in adult oncology patients as an effective alternative to intravenous sedation : a pilot study].

[Type 1 diabetes, towards new horizons].

Structure-activity profiling of indazole-based derivatives as spinster homolog 2 (Spns2)-dependent S1P release inhibitors.

Triterpenoids and lignans from the stems of Tripterygium wilfordii and their hepatoprotective activities.

An integrated in vitro and in silico approach to evaluate the safety and wound healing potential of Dracocephalum moldavica L. seed oil.

Unraveling the allosteric inhibition mechanism of TLR2 by CU-CPT22: A combined DFT and enhanced sampling MD study.

Discovery of pyrimidine-based dual CDK2/TrkA inhibitors: Synthesis, antiproliferative activity, and mechanistic insights.

Oleanolic acid-selenocyanate hybrids trigger replication-associated DNA damage responses and suppress tumour growth in vitro and in vivo.

Related Experiment Videos

[Current therapeutics 2000]

Abstract:

Related Concept Videos

Related Articles